Invest in research and scholarships to further develop the field
Facilitate access for patients to these innovative and life-saving technologies
SIGN UP FOR OUR NEWSLETTER
CONNECT WITH US
Trial begins for Clarity Pharmaceuticals's #breastimaging radiotracer copper-64 SAR-Bombesin. The data emerging from this study will represent a great step forward to progress this product into other #diagnostic & #therapeutic trials in a range of cancers
What we do...
We strive to connect patients, practitioners and experts in the nuclear medicine field by improving access to cancer treatments and clinical trials worldwide. The Oncidium foundation leads the way in this patient-focused science, by providing support to advance the availability of Radiotherapeutics technologies and facilitate worldwide access to patients.